Sekwencjonowanie całego genomu ujawnia genetyczne przyczyny epilepsji u dzieci w Turcji
Whole-exome sequencing reveals the neurogenetic spectrum of pediatric epilepsy in Türkiye
W skrócie
Badacze przeanalizowali DNA 690 dzieci i młodych ludzi z epilepsją, aby znaleźć geny odpowiadające za tę chorobę. U prawie 30% pacjentów odkryli szkodliwe mutacje genetyczne, w tym wiele całkowicie nowych, nigdy wcześniej nieznanych wariantów. Wyniki pokazują, że badanie genetyczne jest ważnym narzędziem do diagnozowania epilepsji u dzieci i dostarczają nowe informacje na temat genetycznych przyczyn tej choroby w populacji tureckiej.
Oryginalny abstract (angielski)
Epilepsy is a clinically and genetically heterogeneous neurodevelopmental disorder, and diagnostic yield from next-generation sequencing varies substantially across cohorts and health-care settings. Population-specific data remain particularly limited for pediatric patients from underrepresented regions. In this retrospective two-center study, we evaluated 690 individuals with epilepsy onset at 18 years of age or younger who underwent whole-exome sequencing between January 2020 and April 2025. Patients with congenital infection, brain trauma, stroke, or perinatal asphyxia as the primary cause of epilepsy were excluded. Pathogenic or likely pathogenic findings were identified in 205 of 690 patients (29.7%). Single-nucleotide variants (SNVs) and insertions/deletions (indels) accounted for 195 patients (28.2%), whereas clinically relevant copy number variants accounted for 10 patients (1.4%). The cohort included 370 males (53.6%) and 320 females (46.4%). We identified 68 rare SNVs and indels, of which 48 were classified as novel because they were absent from ClinVar, gnomAD, and dbSNP and had not been reported in the published literature at the time of analysis. In addition, four variants with rs identifiers lacked ClinVar records and prior case-based publications, and 15 variants had previously been reported only once. Eleven copy number variants were detected in 10 patients; all but one were confirmed by orthogonal testing. Several findings were considered of particular neurogenetic interest, including variants in genes with synaptic or ion-channel relevance and rare recurrent findings that may broaden the recognized phenotypic spectrum of pediatric epilepsy. Overall, this study supports the clinical utility of whole-exome sequencing in pediatric epilepsy and provides population-specific neurogenetic data from Türkiye, while also highlighting a subset of rare findings that require replication and functional validation.